Chronic Kidney Disease Registry Platform Study
← catalyst calendarNCT06117852 · readout in 834 d
Sponsored by AstraZeneca (industry) · AZN — their whole pipeline →.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
5,000estimated
Sites
34
Country
China
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2023-11-28 | actual | When the study began enrolling |
| Primary completion | 2028-11-30 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2028-11-30 | estimated | The whole study's end, after follow-up |
| First posted | 2023-11-07 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-08-19 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Chronic Kidney Diseases
Primary outcomes
what the primary-completion date above is the date OFDisease Progression in CKD Patients
measured From 2023 to 2027
Clinical Outcomes in CKD Patients - Renal Outcomes
measured From 2023 to 2027
Clinical Outcomes in CKD Patients - Cardiovascular Outcomes
measured From 2023 to 2027
Clinical Outcomes in CKD Patients - Cardiac and Renal Composite Outcomes
measured From 2023 to 2027
Clinical Outcomes in CKD Patients - All-cause Mortality
measured From 2023 to 2027
Changes in Patient Conditions - Changes in Proteinuria
measured From 2023 to 2027
Estimates of Changes in Patient Conditions - Changes in eGFR
measured From 2023 to 2027
Publications
- PMID 41152758 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · AZN's whole pipeline · Catalyst calendar · Every registered study · What changed